Protagonist Therapeutics Inc (PTGX)

Exchange
NASDAQ
Symbol
PTGX
Sector
Life Sciences
Industry
Pharmaceutical Preparations
Description
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical needs. The company is headquartered in Newark, California.
Country
USA

Stock price

At close: November 4, 2025

  • Open
    75.44
  • High
    78.01
  • Low
    75.44
  • Close
    76.50
  • Volume
    1,027,990

Financial ratios

Dec 31, 2024